• Phenacetin in Intestinal Organoid PK: Mechanisms and Mode...

  2025-09-29

  Explore the role of Phenacetin as a non-opioid analgesic in advanced pharmacokinetic studies using hiPSC-derived intestinal organoids. This article uniquely focuses on mechanistic insights and model advancements, offering deep scientific value for researchers using N-(4-ethoxyphenyl)acetamide in drug absorption and metabolism research.

• Phenacetin in Translational PK: Bridging Bench and Biorel...

  2025-09-28

  Explore the scientific and translational impact of Phenacetin, a non-opioid analgesic, in next-generation pharmacokinetic studies. This article uniquely integrates mechanistic insights and practical protocols for researchers using advanced human organoid systems.

• Phenacetin in Translational Pharmacokinetics: Bridging In...

  2025-09-27

  Explore the role of Phenacetin as a non-opioid analgesic in translational pharmacokinetics, focusing on its unique solubility, metabolism, and nephropathy risk. This in-depth analysis examines how advanced hiPSC-derived intestinal organoids are transforming scientific research use and bridging the gap between in vitro and in vivo drug studies.

• Phenacetin in Translational Drug Absorption: Beyond Organ...

  2025-09-26

  Explore Phenacetin, a non-opioid analgesic, as a benchmark compound for unraveling human drug absorption and pharmacokinetics. This article uniquely analyzes how Phenacetin enables translational research beyond standard organoid models, with technical insights on solubility, safety, and future directions.

• Phenacetin in Translational PK: Beyond Organoids to Syste...

  2025-09-25

  Explore the versatile role of Phenacetin, a non-opioid analgesic, in translational pharmacokinetic research. This article uniquely connects organoid-based absorption studies with systemic drug disposition, offering new perspectives on N-(4-ethoxyphenyl)acetamide for advanced scientific research.

• Phenacetin in Human Intestinal Organoid Pharmacokinetics:...

  2025-09-24

  Explore the advanced scientific applications of Phenacetin as a non-opioid analgesic in pharmacokinetic studies using hiPSC-derived human intestinal organoids. This article goes beyond solubility, offering mechanistic insights and methodological innovation for scientific research use.

• Phenacetin in Scientific Research: Solubility, Metabolism...

  2025-09-23

  Explore the applications of Phenacetin as a non-opioid analgesic in scientific research, focusing on its solubility characteristics and use in advanced pharmacokinetic modeling with hiPSC-derived intestinal organoids. This article provides technical insights for researchers leveraging Phenacetin in modern in vitro systems.

• Phenacetin in hiPSC-Intestinal Organoid PK Studies: Solub...

  2025-09-22

  Explore the application of Phenacetin, a non-opioid analgesic, in advanced pharmacokinetic research using hiPSC-derived intestinal organoids. This article examines its physicochemical properties, solubility in ethanol and DMSO, and addresses the challenges of nephropathy and safety in scientific research use.

• Phenacetin in Pharmacokinetic Research: Solubility, Model...

  2025-09-19

  Explore the scientific applications of Phenacetin as a non-opioid analgesic in advanced pharmacokinetic studies, with a focus on its solubility characteristics and analytical use in organoid models. This article provides practical guidance for researchers leveraging N-(4-ethoxyphenyl)acetamide in cutting-edge scientific research.

• Phenacetin in Modern Non-Opioid Analgesic Research: Pharm...

  2025-09-18

  This article explores the application of Phenacetin (N-(4-ethoxyphenyl)acetamide) in contemporary pharmacokinetic and drug absorption studies. Focusing on its role as a non-opioid analgesic and model compound, we examine its solubility, safety considerations, and utility in advanced in vitro systems for scientific research use.

• br Materials and Methods br Results

  2025-03-03

  

  Materials and Methods Results A total of 28 NSCLC tumor samples from 26 patients (2 patients with paired tumor samples) were included. According to the initial FISH (Abbott Molecular probes) and IHC results, 13 samples were ALK IHC+FISH+, 5 samples were ALK IHC+FISH−, 2 samples (from the same

• Pioneering studies on the immunomodulatory role

  2025-03-03

  

  Pioneering studies on the immunomodulatory role of adenosine date back to the early ‘70 s of last century (Fig. 1), when the critical role of this nucleoside in shaping the development and the activity of several immune cell populations was first established [[18], [19], [20], [21], [22]]. This then

• Interestingly as observed with Treg cells

  2025-03-03

  

  Interestingly, as observed with Treg cells, adenosine can regulate the function of Breg cells, a subset of immunosuppressive cells that support immunological tolerance [115]. In particular, Bregs were able to regulate both their own function and T cell activity via an adenosine signaling originating

• Recently biosensors based on enzyme mimicking organic inorga

  2025-03-03

  

  Recently, biosensors based on enzyme-mimicking organic-inorganic hybrid nanomaterials such as protein or DNA-Cu nanoflowers (Batule et al., 2015, Park et al., 2017), Fe-aminoclay (Lee et al., 2013), and MOFs (Ai et al., 2013, Dong et al., 2015, Feng et al., 2012, Liu et al., 2013, Qin et al., 2013,

• br Conflict of interest statement br Benign prostatic

  2025-03-03

  

  Conflict of interest statement Benign prostatic hyperplasia (BPH) is a highly complex process characterized by an increased number of epithelial and stromal CB-5083 in the transition zone. , , Autopsy studies by McNeal detail the evolution of histological changes within these 2 cellular compa

15751 records 1/1051 page Next 12345 下5页 Last page